Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St SE
# MMC284
Minneapolis, MN 55455Phone+1 612-626-5454
Education & Training
University of MinnesotaResidency, Internal Medicine, 2018 - 2021- University of Minnesota Medical SchoolClass of 2018
Certifications & Licensure
MN State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun
Research and Practice in Thrombosis and Haemostasis. 2024-03-01 - 2 citationsA descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun
Blood Advances. 2024-02-13 - 17 citationsRace, rituximab, and relapse in TTP.Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian
Blood. 2022-09-22
Abstracts/Posters
- Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian PopulationsElizabeth Davis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraElizabeth Davis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
